Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2015

01-07-2015 | Article

Prevalence of Whipple's disease in north-western Italy

Authors: F. Biagi, D. Balduzzi, P. Delvino, A. Schiepatti, C. Klersy, G. R. Corazza

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2015

Login to get access

Abstract

Whipple's disease (WD) is a rare systemic infection due, in genetically susceptible individuals, to Tropheryma whipplei, a heterogeneous Gram-positive actinobacteria. Although it has already been recognised that WD affects mainly middle-aged Caucasian men, the prevalence of WD is virtually unknown. The annual incidence of WD in the general population is said to be less than 1 per 1,000,000, but scientific evidence for these figures is still lacking. On the basis of the number of patients recorded with a diagnosis of Whipple’s disease in the regional registers for rare diseases of Lombardia, Liguria and Piemonte-Valle d'Aosta regions, we studied the prevalence of WD in the north-western part of Italy. Forty-six patients with Whipple’s disease were recorded in these regions (13 females; mean age at diagnosis 52.1 ± 11.1 years). Since 16,130,725 inhabitants live in these four regions, prevalence of WD in the general population is 3/106 and almost 30 % of the patients are females. WD is certainly a rare disease but it also affects women in a considerable proportion of cases.
Literature
1.
go back to reference Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T et al (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136:2289–94PubMedCrossRef Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T et al (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136:2289–94PubMedCrossRef
2.
go back to reference Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Mytilineos J et al (2012) Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis 31:3145–50PubMedCrossRef Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Mytilineos J et al (2012) Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis 31:3145–50PubMedCrossRef
3.
go back to reference Li W, Fennolar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T et al (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–7PubMedCrossRef Li W, Fennolar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T et al (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–7PubMedCrossRef
4.
go back to reference Moos V, Schneider T (2011) Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30:1151–8PubMedCrossRef Moos V, Schneider T (2011) Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30:1151–8PubMedCrossRef
5.
go back to reference Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D (2008) Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8:179–90PubMedCrossRef Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D (2008) Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8:179–90PubMedCrossRef
6.
go back to reference Dobbins WO III (1987) Whipple's disease. CC Thomas, Springfield, IL, USA Dobbins WO III (1987) Whipple's disease. CC Thomas, Springfield, IL, USA
7.
go back to reference von Herbay A, Otto HF, Stolte M, Borchard F, Kirchner T, Ditton HJ, Maiwald M (1997) Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol 32:52–7CrossRef von Herbay A, Otto HF, Stolte M, Borchard F, Kirchner T, Ditton HJ, Maiwald M (1997) Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol 32:52–7CrossRef
8.
go back to reference Biagi F, Bianchi PI, Campanella J, Zanellati G, Corazza GR (2009) The impact of misdiagnosing celiac disease at a referral centre. Can J Gastroenterol 23:543–5PubMedCentralPubMed Biagi F, Bianchi PI, Campanella J, Zanellati G, Corazza GR (2009) The impact of misdiagnosing celiac disease at a referral centre. Can J Gastroenterol 23:543–5PubMedCentralPubMed
Metadata
Title
Prevalence of Whipple's disease in north-western Italy
Authors
F. Biagi
D. Balduzzi
P. Delvino
A. Schiepatti
C. Klersy
G. R. Corazza
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2357-2

Other articles of this Issue 7/2015

European Journal of Clinical Microbiology & Infectious Diseases 7/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine